Y-mAbs Therapeutics, Inc. (YMAB)
Sep 15, 2025 - YMAB was delisted (reason: acquired by SERB Pharmaceuticals)
8.61
+0.02 (0.23%)
Inactive · Last trade price on Sep 15, 2025

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics is not actively traded anymore. When Y-mAbs Therapeutics last traded, it had a market cap or net worth of $391.22 million.

Market Cap
391.22M
Enterprise Value
332.06M
1-Year Change
-42.96%
Ranking
Category
Stock Price
$8.61

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $391.22M, a decrease of -50.90%. That is a compound annual growth rate of -9.68%.

History

DateMarket Cap% Change
Sep 15, 2025391.22M11.56%
Dec 31, 2024350.70M17.88%
Dec 29, 2023297.50M39.61%
Dec 30, 2022213.10M-69.88%
Dec 31, 2021707.47M-64.73%
Dec 31, 20202.01B61.56%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Sep 21, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition